U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
154201154201Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar HyponatremiaRecruitingNo Results AvailableHyponatremiahttps://ClinicalTrials.gov/show/NCT00541944
154202154202Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy WomenCompletedNo Results AvailableSkin DiseasesDrug: Dietary Supplement: LifePak Nanohttps://ClinicalTrials.gov/show/NCT00541931
154203154203COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart OperationsWithdrawnNo Results AvailableOther Functional Disturbances Following Cardiac Surgery|Memory DisordersDrug: Diprivan (propofol, Astra Zeneca)|Drug: Sevorane (sevoflurane, Abbott)https://ClinicalTrials.gov/show/NCT00541918
154204154204Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical DystoniaCompletedNo Results AvailableCervical DystoniaDrug: NT 201https://ClinicalTrials.gov/show/NCT00541905
154205154205Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum AlbumineWithdrawnNo Results AvailableIn Vitro Fertilization|InfertilityOther: Medium with no human serum albumine added|Other: Conventional mediumhttps://ClinicalTrials.gov/show/NCT00541892
154206154206Obesity and Diabetes Prevention Through Science EnrichmentCompletedNo Results AvailableType 2 Diabetes|ObesityBehavioral: Program ENERGY|Other: comparisonhttps://ClinicalTrials.gov/show/NCT00541879
154207154207Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in HumansCompletedNo Results AvailableAcute Myeloid LeukemiaDrug: voreloxin injection and cytarabinehttps://ClinicalTrials.gov/show/NCT00541866
154208154208CCB Safety Study in Treatment of Hypertension of ADPKDNot yet recruitingNo Results AvailableKidney, Polycystic, Autosomal DominantDrug: Candesartan|Drug: Candesartan and Cilnidipine|Drug: Candesartan plus non-CCB agentshttps://ClinicalTrials.gov/show/NCT00541853
154209154209Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue SarcomaRecruitingNo Results AvailableSoft Tissue SarcomaDrug: Sorafenibhttps://ClinicalTrials.gov/show/NCT00541840
154210154210Skeletal Muscle and Platelet Mitochondrial Dysfunction During SepsisCompletedNo Results AvailableSevere Sepsis|Septic Shockhttps://ClinicalTrials.gov/show/NCT00541827
154211154211Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft FunctionRecruitingNo Results AvailableChronic Allograft NephropathyDrug: Cyclosporinehttps://ClinicalTrials.gov/show/NCT00541814
154212154212Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiographyCompletedNo Results AvailableHeart Failure, Congestive|Antineoplastic AgentsDevice: Doppler-echocardiography and acoustic cardiographyhttps://ClinicalTrials.gov/show/NCT00541801
154213154213Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen DeprivationCompletedNo Results AvailableProstate CancerOther: Administration of Common Sagehttps://ClinicalTrials.gov/show/NCT00541788
154214154214Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)CompletedHas ResultsType 2 Diabetes MellitusDrug: Sitagliptin|Drug: Comparator: Rosiglitazone|Drug: Comparator: Placebo|Drug: Comparator: Metforminhttps://ClinicalTrials.gov/show/NCT00541775
154215154215Regulation of Fat-stimulated Neurotensin Secretion in Healthy SubjectsCompletedNo Results AvailableHealthyDietary Supplement: Fat perfusion to the small intestinehttps://ClinicalTrials.gov/show/NCT00541762
154216154216A Study of rhuMAb IFNalpha in Adults With Systemic Lupus ErythematosusCompletedNo Results AvailableSystemic Lupus ErythematosusDrug: rhuMAb IFNalphahttps://ClinicalTrials.gov/show/NCT00541749
154217154217Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic MigraineCompletedNo Results AvailableFamilial Hemiplegic MigraineDrug: Nitroglycerinehttps://ClinicalTrials.gov/show/NCT00541736
154218154218Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital WrinklesCompletedNo Results AvailableLateral Periorbital WrinklesDrug: IncobotulinumtoxinA (Xeomin)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00541723
154219154219Effect of Genistein in Women With Metabolic SyndromeCompletedNo Results AvailableMetabolic SyndromeDietary Supplement: genistein|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT00541710
154220154220Eze/Simva Switch Study in Diabetics (0653A-807)CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks|Drug: Comparator: atorvastatin / Duration of Treatment: 6 Weekshttps://ClinicalTrials.gov/show/NCT00541697
154221154221Health Assessment Study (0954-946)CompletedNo Results AvailableHypertensionDrug: MK0954, /Duration of Treatment : 16 Weeks|Drug: Comparator : atenolol /Duration of Treatment : 16 Weekshttps://ClinicalTrials.gov/show/NCT00541684
154222154222Prevention of Narcotic-Induced NauseaTerminatedHas ResultsNauseaDrug: Saline|Drug: Phenerganhttps://ClinicalTrials.gov/show/NCT00541671
154223154223A Study of a 35 mg Delayed Release Formulation of Risedronate for OsteoporosisCompletedHas ResultsPostmenopausal OsteoporosisDrug: risedronate|Drug: risedronate|Drug: risedronatehttps://ClinicalTrials.gov/show/NCT00541658
154224154224Transient Osteoporosis of Pregnancy: A Possible Peptide MediatorSuspendedNo Results AvailableTransient Osteperosishttps://ClinicalTrials.gov/show/NCT00541645
154225154225BacLite Rapid MRSA Clinical PerformanceTerminatedNo Results AvailableMethicillin Resistancehttps://ClinicalTrials.gov/show/NCT00541632
154226154226Sympathetic Overactivity in Essential HypertensionWithdrawnNo Results AvailableHypertension|Proteinuriahttps://ClinicalTrials.gov/show/NCT00541619
154227154227Pharmacist Assisted Medication Program Enhancing the Regulation of DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Other: Pharmacist collaboration in diabetes care|Other: Usual carehttps://ClinicalTrials.gov/show/NCT00541606
154228154228Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic PseudocystsTerminatedHas ResultsPancreatic PseudocystProcedure: Pancreatic Pseudocystgastrostomyhttps://ClinicalTrials.gov/show/NCT00541593
154229154229Comparative Results of Conservatively and Surgically Treated Adolescents With Triplane and Juvenile Tillaux Ankle Fractures After Skeletal MaturityTerminatedNo Results AvailableAnkle Injurieshttps://ClinicalTrials.gov/show/NCT00541580
154230154230BMS-646256 in Obese and Overweight Type 2 DiabeticsWithdrawnNo Results AvailableObesity and Type 2 DiabetesDrug: ibipinabanthttps://ClinicalTrials.gov/show/NCT00541567

* Görseller ve İçerik tekif hakkına sahip olabilir